home.social

#kp_3_1_1 — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #kp_3_1_1, aggregated by home.social.

  1. Here's the latest variant picture for the United Kingdom.

    DeFLuQE variants continue to dominate, however growth appears to have stalled.

    XEC.* growth continued, to around 35%.

    #COVID19 #UK #DeFLuQE #KP_3_1_1 #FLiRT #FLuQE #XEC
    🧵

  2. Here's the latest variant picture for the United Kingdom.

    DeFLuQE variants continue to dominate.

    FLiRT and FLuQE variants have been overtaken by XEC.*, growing to around 32%.

    #COVID19 #UK #DeFLuQE #KP_3_1_1 #FLiRT #FLuQE #XEC
    🧵

  3. Here's the latest variant picture for Europe (excluding the UK).

    DeFLuQE variants continue to dominate, but their growth seems to have ended.

    FLiRT and FLuQE variants have been overtaken by XEC.*, growing strongly to around 28%.

    #COVID19 #EUR #DeFLuQE #KP_3_1_1 #FLiRT #FLuQE #XEC
    🧵

  4. Here's the latest variant picture for the United Kingdom.

    DeFLuQE variants continue to dominate.

    FLiRT and FLuQE variants have been overtaken by XEC.*.

    Data from England lags by around a week, which might have skewed the latest results.

    #COVID19 #UK #DeFLuQE #KP_3_1_1 #FLiRT #FLuQE #XEC
    🧵

  5. Here's the latest variant picture for Europe (excluding the UK).

    DeFLuQE variants continue to dominate, but their growth seems to have ended.

    FLiRT and FLuQE variants have been overtaken by XEC.*, growing strongly to around 24%.

    #COVID19 #EUR #DeFLuQE #KP_3_1_1 #FLiRT #FLuQE #XEC
    🧵

  6. Here's the latest variant picture for the United Kingdom.

    DeFLuQE variants continue to dominate, but their growth seems to have ended.

    FLiRT and FLuQE variants have been overtaken by XEC.*, growing strongly around 23%.

    #COVID19 #UK #DeFLuQE #KP_3_1_1 #FLiRT #FLuQE #XEC
    🧵

  7. Here's the latest variant picture for Europe (excluding the UK).

    DeFLuQE variants continue to dominate, but their growth seems to have ended.

    FLiRT and FLuQE variants have been overtaken by XEC.*, growing strongly to around 22%.

    #COVID19 #EUR #DeFLuQE #KP_3_1_1 #FLiRT #FLuQE #XEC
    🧵

  8. Here's the latest variant picture for the United Kingdom.

    DeFLuQE variants continue to dominate, but their growth seems to have ended.

    FLiRT and FLuQE variants have been overtaken by XEC.*, growing strongly around 17%.

    #COVID19 #UK #DeFLuQE #KP_3_1_1 #FLiRT #FLuQE #XEC
    🧵

  9. Here's the latest variant picture for Europe (excluding the UK).

    DeFLuQE variants (KP.3.1.1 and descendants) continue to dominate.

    FLiRT and FLuQE variants have now been overtaken by XEC.*, growing strongly to around 21%.

    #COVID19 #EUR #DeFLuQE #KP_3_1_1 #FLiRT #FLuQE #XEC
    🧵

  10. Here's the latest variant picture for the United Kingdom.

    DeFLuQE variants (KP.3.1.1 and descendants) continue to dominate.

    FLiRT and FLuQE variants have now been overtaken by XEC.*, growing strongly to around 15%.

    #COVID19 #UK #DeFLuQE #KP_3_1_1 #FLiRT #FLuQE #XEC
    🧵

  11. Here's the latest variant picture for Australia.

    DeFLuQE variants (KP.3.1.1 and descendants) continue to dominate FLiRT and FLuQE variants.

    XEC.* has grown steadily to around 10%.

    #COVID19 #Australia #FLiRT #FLuQE #DeFLuQE #KP_3_1_1 @auscovid19
    🧵

  12. Here's the latest variant picture for Europe (excluding the UK).

    DeFLuQE variants (KP.3.1.1 and descendants) continue to dominate, with FLiRT and FLuQE variants (KP.3.*) in decline.

    XEC.* grew strongly to around 20% frequency.

    #COVID19 #EUR #DeFLuQE #KP_3_1_1 #FLiRT #FLuQE #XEC
    🧵

  13. Variants: JN.1 vs KP.2 vs KP.3.1.1

    What is the most common COVID-19 variant right now and how does it compare to the JN.1 variant that swept the world almost a year ago? What do the variant designations like KP.3.1.1 mean? How important is just 1 mutation? Can just 1 mutation potentially affect our immunity and how vaccines are designed? Read on to find out answers to this and more. 🧵 1/

    #Variants
    #COVID
    #Immunity
    #JN1
    #kp_3_1_1